What Would You Do? Specialists’ Perspectives on Cancer Genetic Testing, Prophylactic Surgery, and Insurance Discrimination
- 12 June 2000
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (12) , 2484-2492
- https://doi.org/10.1200/jco.2000.18.12.2484
Abstract
PURPOSE: To examine what cancer genetics specialists predict they would do personally if they were at 50% risk of carrying a mutation that predisposes to hereditary breast/ovarian cancer (BRCA1/BRC...Keywords
This publication has 42 references indexed in Scilit:
- Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13American Journal of Human Genetics, 1997
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.Journal of Clinical Oncology, 1996
- Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer familiesNature Genetics, 1996
- Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndromeInternational Journal of Cancer, 1995
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Hereditary Nonpolyposis Colorectal Cancer: the Syndrome, the Genes, and Historical PerspectivesJNCI Journal of the National Cancer Institute, 1995
- Frontometaphyseal dysplasia: Neonatal radiographic diagnosisAmerican Journal of Medical Genetics, 1995
- Unusual case of Smith‐Lemli‐Opitz syndrome “type II”American Journal of Medical Genetics, 1995
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994